Latest Zofran Child Birth Defect Lawsuits
24 June 2015

Infant Birth Defects Data & Zofran Lawsuits In Nevada

There have been various comparative studies conducted by the medical community in an effort to determine the chances of a newborn being born with a birth irregularity like cleft palate, congenital heart abnormalities among others, when Zofran was used by the mother in the early stages of pregnancy. An expectant mom would have used Zofran in her first trimester in order to combat severe morning sickness, also known as Hyperemesis gravidarum (HG). HG is is an extreme case of nausea and vomiting while pregnant, which can lead to weight loss and dehydration as well as imbalanced electrolytes.  To read more about the studies and results visit our about Zofran page.

Zofran is a drug that was originally designed to be an anti-nausea drug for patients going through cancer treatments and post-operative patients experiencing nausea. The FDA approved Zofran for these specific uses only, in 1991 but the makers of Zofran GlaxoSmithKline (GSK), went ahead and promoted the drug as an off-label drug to be used by pregnant women experiencing HG. The FDA never approved Zofran for this particular use. To date, there have been many lawsuits that have been brought to court stating that Zofran was the agent that caused a baby to be born with birth defects.


Stats About Newborn Birth Defects

For every 33 births in America, there is likely going to be one that will result in a birth defect of sorts. The most recent (2014) Nevada population stands at 2,839,099. Of that figure the estimated number of live child births that were birth defects is 1,430.

A baby being born with some kind of abnormality is not an uncommon occurrence, and defects can range from genetic problems to faulty drugs used while pregnant. Our Zofran attorneys have evaluated Nevada state in order to figure out the possible cases that are there while making use of medical research studies that convey certain abnormality percentages that occur due to using Zofran, as well as accounting for the population, and birth rates in Nevada.

Nevada’s five dominant cities have the following population stats:

  • Las Vegas- 613,599 population
  • Henderson- 277,440 population
  • Reno- 236,995 population
  • North Las Vegas- 230,788 population
  • Paradise- 230,000 population

Potential Cleft Palate & CHDs Cases In Nevada & Its Dominant Cities

Adopting Nevada’s population number of 2,839,099, we conclude that possibly 265 births are some type of cleft palate and roughly 1,165 are considered to be hole in the heart defects, brought on by the usage of Zofran in the first three months of pregnancy.Using the figures from Nevada’s dominant cities, defect cases are as follows:

  • Las Vegas- 338 newborn birth irregularities | roughly 58 cleft palate | roughly 280 CHDs
  • Henderson- 230 newborn birth irregularities | roughly 26 cleft palate | roughly 204 CHDs
  • Reno- 160 newborn birth irregularities | roughly 20 cleft palate | roughly 140 CHDs
  • North Las Vegas- 158 newborn birth irregularities | roughly 21 cleft palate | roughly 137 CHDs
  • Paradise- 157 newborn birth irregularities | roughly 21 cleft palate | roughly 136 CHDs

Documented Birth Abnormalities & Adverse Effects Of Taking Zofran

As clinical studies have referenced already in this article, Zofran has been linked to the heightened potential of a child being born with (but not limited to) abnormalities such as congenital heart abnormalities and cleft palate. Nonetheless, GSk does not take these studies into consideration and refuses to acknowledge that their drug causes birth defects. Lawsuits that have been filed against GSK have to date seen litigants state that these were some of the birth abnormalities their children were born with when a mom took Zofran for morning sickness while pregnant:

  • Atrial Septal Defect
  • Ventricular Septal Defect
  • Kidney Defects
  • Webbed Toes
  • BAS
  • Supraventricular tachycardia
  • Heart murmurs
  • Facial dysmorphia
  • Cleft Palate/Lip

With regard to cleft palate, there has been a specific study conducted by the CDC and Sloan Epidemiology that correlated a 2.37 likelihood of a newborn being born with a cleft palate in circumstances where the mother consumed Zofran in the first few months of critical fetal development. There has even been a lawsuit filed attesting to this reality. Read the cleft palate lawsuit here.

Parents From Nevada Are Reaching Out For Lawsuit Advice is subsidized by the law firms of Monheit Law, Janet Jenner & Suggs, Grant Eisenhofer, Markhoff & Mittman, and Banville Law. These law firms have come together in order to create a website that gives regular news about the Zofran suit. Albeit, our attorneys are not allowed to practice law in Nevada, however, we are allowed to practice law and hold offices in Delaware. It is also important to note that Delaware is the state where GSK has its main offices. This means we are able to fully represent your family in a court of law when you file a suit in Delaware. Click here for our office details.

When you contact us we analyze each case on an individual basis in order to determine how best to file your case. We may advise you to file your case in Delaware, where we have offices and can represent the case ourselves, or the case can be filed at another convenient location. Furthermore, depending on the circumstances surrounding your case, it may make sense to file your suit in Nevada, using our trusted network of legal counsel. Our Zofran lawyers are available to attend to your questions any time of the day.For more information about our Zofran advocates visit this page.

Where To Look For Cleft Palate & CHDs Info In Nevada

University of Nevada School Of Medicine:

Sunny Smiles:

High Risk Pregnancy Center:

Sunrise Children’s Hospital:

Call Now Button